Form 4: DENTSPLY SIRONA Director Willie Deese Granted 13,880 Restricted Stock Units

DENTSPLY SIRONA Inc. Director Willie A. Deese received a grant of 13,880 Restricted Stock Units, increasing his total beneficial ownership to 57,227.699 shares.

Summary

• Willie A. Deese, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 13,880 shares of common stock.
• The acquisition occurred on May 22, 2025, and was a grant of Restricted Stock Units (RSUs).
• The RSUs were granted at a price of $0, indicating they are part of an equity compensation plan.
• These RSUs will vest in full one year from the grant date.
• Following this transaction, Mr. Deese's beneficial ownership in DENTSPLY SIRONA Inc. increased to 57,227.699 shares.

Sentiment

Score: 7

Explanation: The grant of equity to a director is generally viewed positively as it aligns the director's financial interests with the long-term performance of the company and its shareholders. It is a routine compensation event rather than a significant operational or financial announcement.

Positives

• The grant of Restricted Stock Units to a director aligns management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• Increased beneficial ownership by a director can signal confidence in the company's future prospects.

Negatives

• No immediate cash inflow for the director from this grant, as it is equity-based compensation that vests over time.

Risks

• The value of the granted RSUs is subject to the future performance of DENTSPLY SIRONA Inc.'s stock price.

Future Outlook

The 13,880 Restricted Stock Units granted to Director Willie A. Deese are scheduled to vest in full one year from the grant date, which is May 22, 2025.

Industry Context

The granting of Restricted Stock Units (RSUs) to directors is a common practice in publicly traded companies across various industries, including the dental products and technology sector where DENTSPLY SIRONA operates. This method of compensation is widely used to attract and retain talent, and to align the interests of directors with long-term shareholder value creation.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of director compensation is a standard practice observed across major public companies, including peers in the medical device and dental supply industries such as Henry Schein, Inc. (HSIC) and Align Technology, Inc. (ALGN).
• The vesting schedule of one year is also a common approach for director equity grants, aiming to provide a balance between immediate incentive and long-term commitment.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grant aligns the director's interests with shareholders, potentially leading to decisions that enhance long-term shareholder value.

Next Steps

• The 13,880 Restricted Stock Units granted to Willie A. Deese are expected to vest in full one year from the grant date (May 22, 2025).

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Form 4, insider transaction, Restricted Stock Units, RSU, director compensation, equity grant, beneficial ownership